Breast cancer survival rates have improved considerably in the last few decades in Colombia, but factors that increase the likelihood of patients experiencing cardiovascular side effects, like cardiotoxicity, are not well-known or well-treated.
Kiniksa Pharmaceuticals sees highest filings and grants during April in Q2 2024
Kiniksa Pharmaceuticals has been focused on protecting inventions in Australia(AU) with two publications in Q2 2024 The Australia(AU) Patent Office dominates the patent filings with